scholarly journals Prostate cancer risk and aggressiveness associated with the CYP1B1 4326C/G (Leu432Val) polymorphism: a meta-analysis of 2788 cases and 2968 controls

2012 ◽  
Vol 14 (4) ◽  
pp. 560-565 ◽  
Author(s):  
Jie Yang ◽  
Dong-Liang Xu ◽  
Qiang Lu ◽  
Zhi-Jian Han ◽  
Jun Tao ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Risk ◽  
Meta Analysis ◽  
Prostate Cancer Risk

Coffee Consumption and Prostate Cancer Risk: A Meta-Analysis of Cohort Studies

2015 ◽  
Vol 67 (3) ◽  
pp. 392-400 ◽  
Author(s):  
Huan Liu ◽  
Guang-Hui Hu ◽  
Xing-Chun Wang ◽  
Tian-Bao Huang ◽  
Liang Xu ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Risk ◽  
Cohort Studies ◽  
Meta Analysis ◽  
Prostate Cancer Risk ◽  
Coffee Consumption

scholarly journals Polymorphism in IGFBP3 gene is associated with prostate cancer risk: an updated meta-analysis

2016 ◽  
Vol Volume 9 ◽  
pp. 4163-4171 ◽  
Author(s):  
Yong Xu ◽  
Yungkai Qie ◽  
Xuewu Nian ◽  
Xuesen Liu ◽  
Hailong Hu ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Risk ◽  
Meta Analysis ◽  
Prostate Cancer Risk ◽  
Em Gene

scholarly journals Is acne in adolescence associated with prostate cancer risk? Evidence from a meta-analysis

PLoS ONE ◽  
2018 ◽  
Vol 13 (11) ◽  
pp. e0206249 ◽  
Author(s):  
Xian Zhang ◽  
Yi Lin ◽  
Xiaoning Xie ◽  
Meiya Shen ◽  
Guoping Huang ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Risk ◽  
Meta Analysis ◽  
Prostate Cancer Risk

scholarly journals First-degree family history of breast cancer is associated with prostate cancer risk: a systematic review and meta-analysis

BMC Cancer ◽  
2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Zheng-Ju Ren ◽  
De-Hong Cao ◽  
Qin Zhang ◽  
Peng-Wei Ren ◽  
Liang-Ren Liu ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Prostate Cancer ◽  
Systematic Review ◽  
Family History ◽  
Cancer Risk ◽  
Meta Analysis ◽  
Prostate Cancer Risk ◽  
History Of

scholarly journals Effect of statins type on incident prostate cancer risk: a meta-analysis and systematic review

2017 ◽  
Vol 19 (6) ◽  
pp. 666 ◽  
Author(s):  
Lu Yang ◽  
Qiang Wei ◽  
Ping Tan ◽  
Chen Zhang ◽  
Shi-You Wei ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Systematic Review ◽  
Cancer Risk ◽  
Meta Analysis ◽  
Prostate Cancer Risk

Abstract B29: A meta-analysis of racial disparities in the association between 8q24 and prostate cancer risk

2012 ◽  
Vol 72 (4 Supplement) ◽  
pp. B29-B29
Author(s):  
Douglas K. Price ◽  
Sarah M. Troutman ◽  
Tristan M. Sissung ◽  
Cheryl Cropp ◽  
David J. Venzon ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Risk ◽  
Racial Disparities ◽  
Meta Analysis ◽  
Prostate Cancer Risk

scholarly journals Association between SLCO1B3 gene polymorphism and prostate cancer risk: A meta-analytic study

2018 ◽  
Vol 13 (1) ◽  
pp. 98
Author(s):  
Qunshan Shen ◽  
Yu Liang ◽  
Haibo Li ◽  
Mei Chen ◽  
Jun Zhang ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Risk ◽  
Gene Polymorphism ◽  
Web Of Science ◽  
Prostate Cancer Patient ◽  
Meta Analysis ◽  
Prostate Cancer Risk ◽  
Risk Of Bias ◽  
Cochrane Library ◽  
Statistical Relationship

<p class="Abstract">The aim of this meta-analysis was to assess the association between SLCO1B3 gene polymorphism and prostate cancer risk. PubMed, Embase, Cochrane Library, and Web of Science from inception to September 2017 were searched. Three authors independently selected studies, extracted data and assessed risk of bias. 5 articles published from 2008 to 2013 with 840 patients were included in this meta-analysis and were from Japan, USA and China. The prostate cancer risk of SLCO1B3 (rs4149117, GG) was markedly higher than that of SLCO1B3 (rs4149117, TT/TG, RR= 0.44, 95%CI: 0.39-0.49, p&lt;0.00001), rs4149117 (TT, RR= 0.37, 95%CI: 0.32-0.42, p&lt;0.00001) and rs4149117 (TG, RR= 0.07, 95%CI: 0.05-0.10, p&lt;0.00001). 2 or 5 years risk  free symptoms (RFS) of prostate cancer patient with SLCO1B3 (rs4149117, GG) was markedly higher than that of SLCO1B3 (rs4149117, TT/TG) (RR= -0.17, 95% CI: -0.27--0.07, p= 0.001 and RR= -0.08, 95% CI: -0.16-0.00, p= 0.004). However, no evidence showed there existed significant statistical relationship between SLCO1B3 (rs4149117) and 10 years RFS of prostate cancer (RR= -0.07, 95% CI: -0.19-0.06, p= 0.29). These data suggest that SLCO1B3 (rs4149117, GG) enhanced the RFS of prostate cancer.</p>

Sign in / Sign up

Export Citation Format

Share Document